CO2 Laser Treatment for Burn Scars
Trial Summary
What is the purpose of this trial?
Scarring from burn wounds remains a chronic and often severe sequela of burn injury. Burn wounds may be left to heal by secondary intention or treated with surgical skin grafting; in both circumstances, significant scars likely result. When surgical skin grafting is employed, skin graft harvest sites ("donor sites") likewise result in clinically significant scars. This study will have interventional and observational components. Patients will receive the standard fractional ablative CO2 treatments to their scars resulting from burn wounds allowed to heal by secondary intention and/or those treated with skin grafts. These will be prospectively observed for the duration of the study as well as adjacent normal skin. In addition, a donor site that meets inclusion criteria that would not have otherwise received LSR will be identified as a treatment site. Patients with have one half of their donor sites randomized to standard of care (SOC) treatment, which consists of wound dressings, compression therapy, physical and occupational therapies and the other half randomized to SOC + ablative fractional CO2 laser therapy (LSR).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used oral retinoid medications in the past 6 months.
What data supports the effectiveness of the treatment Fractional CO2 Laser for burn scars?
Is CO2 laser treatment safe for burn scars?
How does the CO2 laser treatment for burn scars differ from other treatments?
The CO2 laser treatment for burn scars is unique because it uses a fractional laser that creates controlled thermal damage, which helps remodel the skin with fewer sessions compared to nonablative lasers. This treatment can be customized for each patient's skin, providing immediate relaxation of scar tension and promoting long-term improvements through molecular changes.23101112
Eligibility Criteria
Adults over 18 with second or third degree burn wounds treated with skin grafts can join this trial. They must have a donor site scar of at least 4x4 inches and be able to visit the clinic for treatments and check-ups. Those with recent infections, pregnancy, nursing, certain medical conditions like Ehlers-Danlos syndrome or AIDS, recent oral retinoid use, or poor nutrition affecting healing cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard fractional ablative CO2 treatments to their scars and are randomized to either standard of care or standard of care plus CO2 laser therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments completed 2 months ± 2 weeks after the final laser treatment
Treatment Details
Interventions
- Fractional CO2 Laser
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medstar Health Research Institute
Lead Sponsor